Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Laurent Villeneuve"'
Autor:
Peggy Dartigues, Anne Chevallier, Olivier Glehen, Laurent Villeneuve, Françoise Galateau Sallé, Eliane Mery, Marie-Hélène Laverriere, Irène Villa, Séverine Valmary-Degano, Gerlinde Averous, Sylvie Isaac, Nazim Benzerdjeb, Juliette Hommell-Fontaine, Vahan Kepenekian
Publikováno v:
Virchows Archiv. 479:927-936
Epithelioid mesothelioma is the most prevalent subtype of diffuse malignant peritoneal mesothelioma. A recently described nuclear-grading system predicted survival in patients with epithelioid malignant pleural mesothelioma. The present study was und
Autor:
Nazim Benzerdjeb, Olivier Harou, Vahan Kepenekian, Laurent Villeneuve, Anne Chevallier, Sylvie Isaac, Peggy Dartigues, Marie-Hélène Laverriere, Irène Villa, Juliette Hommell-Fontaine, Eliane Mery, Françoise Galateau Sallé, Séverine Valmary-Degano, Olivier Glehen, Frédéric Bibeau, Gerlinde Averous
Publikováno v:
Virchows Archiv. 479:765-772
Epithelioid mesothelioma is the most prevalent subtype of diffuse malignant peritoneal mesothelioma. The relationship between a strong adaptive immune response and a better prognosis in malignant solid tumors is widely known. Due to the low incidence
Autor:
Anurag Gupta, Basile Pache, Thomas Steffen, Lilian Roth, Philippe Gertsch, Guillaume Passot, Kuno Lehmann, Vahan Kepenekian, Martin Hübner, Monika Hebeisen, Katharina Frischer-Ordu, Marcel André Schneider, Laurent Villeneuve, Olivier Glehen, Janina Eden, Eva Breuer, Chantal Pauli
Publikováno v:
Journal of the National Cancer Institute, vol. 113, no. 8, pp. 1027-1035
Background Multimodal treatment, including systemic treatment and surgery, improved the prognosis of peritoneal metastasis (PM). Despite all efforts, recurrence rates remain high, and little data are available about clinical behavior or molecular pat
Autor:
Nathalie Laplace, Pierre-Emmanuel Bonnot, Matthieu Siebert, Mohammad Alyami, Guillaume Passot, Laurent Villeneuve, Naoual Bakrin, Olivier Glehen, Frederic Mercier, Vahan Kepenekian
Publikováno v:
EJSO-European Journal of Surgical Oncology
EJSO-European Journal of Surgical Oncology, WB Saunders, 2021, 47, pp.128-133. ⟨10.1016/j.ejso.2019.06.028⟩
EJSO-European Journal of Surgical Oncology, WB Saunders, 2021, 47, pp.128-133. ⟨10.1016/j.ejso.2019.06.028⟩
Background PIPAC is a recent method of intraperitoneal chemotherapy. The aim of this study was to describe the clinical characteristics of the patients who became amenable to CRS & HIPEC after PIPAC treatment. Methods All patients diagnosed with unre
Autor:
Olivia Sgarbura, Julien Péron, Diane Goéré, On Behalf Renape, Olivier Glehen, Isabelle Bonnefoy, Jean-Baptiste Delhorme, Karine Abboud, Vahan Kepenekian, Marc Pocard, Laurent Villeneuve, Nazim Benzerdjeb, Pascal Rousset, Clarisse Eveno
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 805-814 (2021)
Background Multicystic peritoneal mesothelioma (MCPM) is a rare, slowly growing, condition prone to recur after surgery. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) added to complete cytoreductive surgery (CRS) remains controversial
Autor:
S. Carrere, Lucas Sideris, Paolo Sammartino, François Quenet, Catherine Arvieux, Alex Kartheuser, M. Faron, B. J. Moran, I.H.J.T. de Hingh, Pablo Ortega-Deballon, Laurent Villeneuve, Olivier Facy, G. Ferron, David L. Morris, Julio Abba, Diane Goéré, Armando Sardi, M. Limbert, Martin Hübner, Karine Abboud, Frédéric Marchal, R. Lo Dico, Paul H. Sugarbaker, Marc Pocard, Wim Ceelen, Y. Yonemura, Gabriel Liberale, M. Robella, Gérard Lorimier, D. Baratti, Jean-Jacques Tuech, Olivier Glehen, P. Rat
Publikováno v:
EJSO-European Journal of Surgical Oncology
EJSO-European Journal of Surgical Oncology, WB Saunders, 2021, 47, pp.89-100. ⟨10.1016/j.ejso.2020.07.038⟩
European journal of surgical oncology, 47 (1
European Journal of Surgical Oncology, Vol. 47, no. 1, p. 89-100 (2021)
European journal of surgical oncology, vol. 47, no. 1, pp. 89-100
EJSO-European Journal of Surgical Oncology, WB Saunders, 2021, 47, pp.89-100. ⟨10.1016/j.ejso.2020.07.038⟩
European journal of surgical oncology, 47 (1
European Journal of Surgical Oncology, Vol. 47, no. 1, p. 89-100 (2021)
European journal of surgical oncology, vol. 47, no. 1, pp. 89-100
SCOPUS: ar.j
info:eu-repo/semantics/published
info:eu-repo/semantics/published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759f9a4d73543cb080a01a1ea33ec1be
https://hal.archives-ouvertes.fr/hal-03493675
https://hal.archives-ouvertes.fr/hal-03493675
Autor:
Laurent Villeneuve, Sophie Gazzo, François-Noël Gilly, Marine Blanchet, Sylvie Isaac, Wajd Althakfi, Marie Brevet, Eric Piaton, Olivier Glehen
Publikováno v:
Cytopathology. 31:5-11
Objective Diffuse malignant peritoneal mesothelioma (DMPM), represents 30% of all malignant mesothelioma, and is characterised by a difficult diagnosis and different presentations. Immunohistochemistry has improved the diagnostic sensitivity and spec
Autor:
Naoual Bakrin, Eddy Cotte, Pierre Emmanuel Bonnot, François-Noël Gilly, Laurent Villeneuve, Delphine Vaudoyer, Guillaume Passot, Vahan Kepenekian, Olivier Glehen, Nathalie Laplace
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 203:587-595
Resume Les tumeurs primitives malignes du peritoine et les metastases ou carcinoses peritoneales ont ete longtemps considerees comme un stade metastatique terminal. Le developpement de nouvelles techniques de chirurgie de cytoreduction et peritonecto
Autor:
Roubi Kilo, Silvy Laporte, Rama Arab, Sabine Mainbourg, Steeve Provencher, Guillaume Grenet, Laurent Bertoletti, Laurent Villeneuve, Michel Cucherat, Jean-Christophe Lega, META-EMBOL Group
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
This study aimed to explore the validity of the use of the net clinical benefit (NCB), i.e. the sum of major bleeding and thrombotic events, as a potential surrogate for all-cause mortality in clinical trials assessing antithrombotics. Published rand
Autor:
Daniel M. Labow, Nazim Benzerdjeb, Brendan Moran, Vadim Gushchin, Sanket Mehta, Aditi Bhatt, Almog Ben Yacov, Ignace H. J. T. de Hingh, Edward A. Levine, Laurent Villeneuve, Olivier Glehen, Armando Sardi, Loma Parikh, Aviram Nissan, Noah Cohen, Anwar Alshukami, Dario Baratti, Paolo Sammartino, Shoma Barat, Kurtis Campbell, Marcello Deraco, Gaurav Goswami, Kaushal Kundalia, Galal Bashanfer, Delia Cortes-Guiral, Faheez Mohamed, Kiran K. Turaga, Mohammad Alyami, David L. Morris, Samer Alammari, Yutaka Yonemura, Vincent C J van de Vlasakker, Mohammad Adileh, Praveen Kammar, Michelle Sittig, Daniele Biacchi, Kathleen Cummins-Perry, P. Rousset
Publikováno v:
BMJ Open
BMJ Open, Vol 11, Iss 7 (2021)
BMJ Open, Vol 11, Iss 7 (2021)
IntroductionDespite optimal patient selection and surgical effort, recurrence is seen in over 70% of patients undergoing cytoreductive surgery (CRS) for peritoneal metastases (PM). Apart from the Peritoneal Cancer Index (PCI), completeness of cytored